Pantoprazole Kalceks (Pantoprazole)

Pantoprazole Kalceks is a proton‑pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related gastrointestinal conditions:

• Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes healing of the esophageal lining.
• Erosive esophagitis: heals erosions and reduces further damage.
• Peptic ulcer disease: supports ulcer healing and prevents recurrence.
• Zollinger‑Ellison syndrome: controls excessive gastric acid production.
• NSAID‑associated gastric ulcer prevention: lowers risk of ulcer development in at‑risk patients.

• Pantoprazole selectively inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By binding covalently to the pump’s cysteine residues, it blocks the final step of acid secretion, leading to a sustained increase in gastric pH and reduced acidity in the stomach.

Pantoprazole may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: usually self‑limiting.
• Abdominal pain or discomfort.
• Nausea or vomiting.
• Flatulence or gas buildup.
• Constipation.

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis): difficulty breathing, swelling of face or throat.
• Clostridioides difficile‑associated colitis: persistent watery diarrhea.
• Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat.
• Bone fractures: increased risk with long‑term use.
• Acute interstitial nephritis: kidney inflammation.
• Liver enzyme elevations: signs of hepatic stress.

Before initiating therapy with Pantoprazole Kalceks, consider the following safety measures:

• Assess renal function: dose adjustment may be required in severe impairment.
• Review concomitant medications: potential for drug‑drug interactions.
• Monitor for infection: prolonged acid suppression can increase risk of gastrointestinal infections.
• Evaluate bone health: long‑term use may affect calcium absorption.
• Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment.
• Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Pantoprazole can interact with several medicines, altering their effectiveness or safety profile.

Major Interactions (Avoid)

• Ketoconazole or itraconazole: reduced antifungal absorption.
• Atazanavir: decreased antiviral efficacy.
• Clopidogrel: diminished antiplatelet activity.

Moderate Interactions (Monitor Closely)

• Warfarin: possible increase in INR.
• Digoxin: higher serum concentrations.
• Methotrexate: reduced renal clearance may raise toxicity risk.
• Phenytoin: altered plasma levels.
• Iron supplements: decreased iron absorption when taken simultaneously.